For citations:
Polyanskaya E.M., Fedyanin M.Yu., Boyarskikh U.A., Kechin A.A., Moroz E.A., Khrapov E.A., Oskorobin I.P., Shamovskaya D.V., Aliev V.A., Mammadli Z.Z., Tryakin A.A., Filipenko M.L., Tyulendin S.A. The prognostic value of circulating in blood tumor DNA as a marker of minimal residual disease in stage I–III colorectal cancer. Advances in Molecular Oncology. 2022;9(2):32-42. (In Russ.) https://doi.org/10.17650/2313-805X-2022-9-2-32-42
Email this article 